Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GENN Stock Summary
In the News
Genesis HealthCare Announces Universal COVID-19 Vaccination for Employees, Care Partners and Onsite Vendors
KENNETT SQUARE, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Genesis HealthCare, (“Genesis” or “Company”) (OTC PINK: GENN), a national post-acute care provider, announced today that it is adopting a universal COVID-19 vaccination requirement for employees, care partners, and onsite vendors across the Company.
GENN Financial details
Company Rating
Sell
Market Cap
11.17K
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
0.13
Dividend %
11.82K%
Employees
44K
Optionable
No
Shortable
Yes
Earnings
19 Mar 2024
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
0.18
Current Ratio
0.23
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
1%
ROA
-3%
ROE
11%
ROC
0.2%
Gross Margin
42%
Oper. Margin
1%
Profit Margin
-3%
Payout
-
Shs Outstand
111.73M
Shs Float
107.73M
-
-
-
-
Target Price
-
52W Range
1.0E-4-0.37555
52W High
-
52W Low
-
RSI
33.49
Rel Volume
0.01
Avg Volume
31.82K
Volume
400
Perf Week
0%
Perf Month
0%
Perf Quarter
-
Perf Half Y
-35.29%
-
-
-
-
Beta
-0.49
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0011
Change
0%
GENN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 49.27 | 27.62 | 34.92 | 0 | 0 | |
Net income per share | -2.33 | 0.05 | -0.92 | 0 | 0 | |
Operating cash flow per share | 0.18 | -0.04 | 2.82 | 0 | 0 | |
Free cash flow per share | -0.32 | -0.42 | 2.33 | 0 | 0 | |
Cash per share | 0.56 | 0.27 | 2.25 | 0 | 0 | |
Book value per share | -20.24 | -6.55 | -7.33 | 0 | 0 | |
Tangible book value per share | -22.27 | -7.6 | -11.89 | 0 | 0 | |
Share holders equity per share | -20.24 | -6.55 | -7.33 | 0 | 0 | |
Interest debt per share | 53.21 | 28.18 | 35.28 | 0 | 0 | |
Market cap | 119.19M | 271.11M | 54.21M | 0 | 0 | |
Enterprise value | 4.88B | 4.43B | 3.65B | 0 | 0 | |
P/E ratio | -0.51 | 36.27 | -0.52 | 0 | 0 | |
Price to sales ratio | 0.02 | 0.06 | 0.01 | 0 | 0 | |
POCF ratio | 6.41 | -37.83 | 0.17 | 0 | 0 | |
PFCF ratio | -3.66 | -3.88 | 0.21 | 0 | 0 | |
P/B Ratio | -0.06 | -0.25 | -0.07 | 0 | 0 | |
PTB ratio | -0.06 | -0.25 | -0.07 | 0 | 0 | |
EV to sales | 0.98 | 0.97 | 0.93 | 0 | 0 | |
Enterprise value over EBITDA | 11 | 12.71 | 23.98 | 0 | 0 | |
EV to operating cash flow | 262.71 | -618.3 | 11.57 | 0 | 0 | |
EV to free cash flow | -149.91 | -63.39 | 14.04 | 0 | 0 | |
Earnings yield | -1.97 | 0.03 | -1.91 | 0 | 0 | |
Free cash flow yield | -0.27 | -0.26 | 4.8 | 0 | 0 | |
Debt to equity | -2.4 | -4.14 | -4.65 | 0 | 0 | |
Debt to assets | 1.15 | 0.96 | 0.94 | 0 | 0 | |
Net debt to EBITDA | 10.73 | 11.93 | 23.63 | 0 | 0 | |
Current ratio | 0.96 | 0.77 | 0.23 | 0 | 0 | |
Interest coverage | 0.45 | 1.25 | 0.33 | 0 | 0 | |
Income quality | -0.05 | -0.96 | -3.05 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.06 | 0.12 | 0.14 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.05 | 0.04 | 0.04 | 0 | 0 | |
Capex to operating cash flow | -2.75 | 8.75 | -0.18 | 0 | 0 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | 0 | 0 | |
Capex to depreciation | -0.23 | -0.51 | -0.52 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 32.57 | 2.58 | 12.35 | 0 | 0 | |
ROIC | 0.03 | 0.03 | 0.01 | 0 | 0 | |
Return on tangible assets | -0.06 | 0 | -0.03 | 0 | 0 | |
Graham Net | -56.91 | -31.72 | -40.78 | 0 | 0 | |
Working capital | -36.59M | -242.32M | -2.98B | 0 | 0 | |
Tangible asset value | -2.25B | -1.26B | -1.33B | 0 | 0 | |
Net current asset value | -5.43B | -4.92B | -4.36B | 0 | 0 | |
Invested capital | -2.4 | -4.14 | -4.65 | 0 | 0 | |
Average receivables | 673.43M | 595.18M | 497.28M | 213.46M | 0 | |
Average payables | 260.21M | 236.59M | 224.87M | 105.68M | 0 | |
Average inventory | 36.88M | 68.43M | 123.05M | 91.5M | 0 | |
Days sales outstanding | 45.67 | 45.38 | 39.89 | 0 | 0 | |
Days payables outstanding | 30.75 | 35.01 | 34.19 | 0 | 0 | |
Days of inventory on hand | 9.66 | 9.27 | 29.61 | 0 | 0 | |
Receivables turnover | 7.99 | 8.04 | 9.15 | 0 | 0 | |
Payables turnover | 11.87 | 10.42 | 10.67 | 0 | 0 | |
Inventory turnover | 37.78 | 39.38 | 12.33 | 0 | 0 | |
ROE | 0.12 | -0.01 | 0.13 | 0 | 0 | |
Capex per share | -0.51 | -0.38 | -0.5 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 0 | 0 | 0 | 0 | 0 | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 0 | 0 | 0 | 0 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 0 | 0 | 0 | 0 | 0 | |
Tangible asset value | 0 | 0 | 0 | 0 | 0 | |
Net current asset value | 0 | 0 | 0 | 0 | 0 | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
GENN Frequently Asked Questions
What is Genesis Healthcare, Inc. stock symbol ?
Genesis Healthcare, Inc. is a US stock , located in Kennett square of Pa and trading under the symbol GENN
What is Genesis Healthcare, Inc. stock quote today ?
Genesis Healthcare, Inc. stock price is $0.0011 today.
Is Genesis Healthcare, Inc. stock public?
Yes, Genesis Healthcare, Inc. is a publicly traded company.